Newsmeme!
Discover News you didn't know existed
Protease
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Activist Investor Pushes Celera to Divest Merck Bone Drug Royalties
Published February 9, 2010, 6:05 pm, BioWorld
The Biotechnology Value Fund (BVF), a historically activist investor group, revealed in a 13-D filing Tuesday the reason for its recent interest in diagnostics firm Celera Corp.: BVF wants Celera to spin out its royalty interest in Merck & Co. Inc.'s Phase III osteoporosis drug, odanacatib.
Gilead's quad pill for AIDS patients may overtake Atripla, COO says
Published February 9, 2010, 4:49 pm, San Jose Mercury News
Gilead Sciences, the world's biggest maker of AIDS medicines, will begin three final-stage tests this year for a four-drug combination pill against HIV that has the potential to generate $4 billion a year by 2014.
Gilead Quad Pill May Overtake Atripla, Milligan Says (Update2)
Published February 9, 2010, 1:36 pm, Bloomberg
Feb. 9 (Bloomberg) -- Gilead Sciences Inc ., the world’s biggest maker of AIDS medicines, will begin three final-stage tests in 2010 for a four-drug combination pill against HIV that has the potential to generate $4 billion a year.
Ambrilia Biopharma Provides Bi-Weekly Status Update
Published February 8, 2010, 9:28 am, Marketwire
MONTREAL, QUEBEC--(Marketwire - Feb. 8, 2010) - A
Ambrilia Biopharma Provides Bi-Weekly Status Update
Published February 8, 2010, 9:17 am, Marketwire via Yahoo! Finance
MONTREAL, QUEBEC--(Marketwire - 02/08/10) - ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS Ambrilia Biopharma Inc. (TSX: AMB - News ) is providing today its bi-weekly Default Status Report under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("Default Status Report"). On November 16, 2009, Ambrilia announced that the filing of its interim financial statements ...
YOU ARE HERE:
Published February 8, 2010, 5:46 am, Aidsmap
Amongst patients experiencing a rebound in viral load, those taking 3TC (lamivudine, Epivir ) in combination with tenofovir ( Viread ) were more likely than those taking FTC (emtricitabine, Emtriva ) and tenofovir to develop a number of key resistance mutations.
Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an ...
Published February 8, 2010, 12:08 am, PRWeb
Mimotopes' PepSets™ to be used to identify novel proteins from the malaria parasite for next generation vaccine development (PRWeb Feb 8, 2010) Read the full story at http://www.prweb.com/releases/2010/02/prweb3564994.htm
Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an ...
Published February 7, 2010, 11:01 pm, PRWeb via Yahoo! News
Mimotopes' PepSets™ to be used to identify novel proteins from the malaria parasite for next generation vaccine development
Novel Therapies Could Improve Potency Of Existing AIDS Treatments, Help To Combat Drug-Resistant Virus Strains
Published February 5, 2010, 3:34 am, Medical News Today
A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS. The discovery lays the foundation for the development of a new class of anti-HIV drugs to enhance existing therapies, treat drug-resistant strains of the disease, and slow the evolution of ...
US scientists find ideal target for malaria therapy
Published February 4, 2010, 7:24 pm, People's Daily
Scientists at Washington University School of Medicine in St. Louis have identified a protein made by the malaria parasite that is essential to its ability to take over human red blood cells, the university said Wednesday in a statement. Malaria, which is spread by mosquito bites, kills between one million and three million people annually in developing countries. Death results from damage to ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |